These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19760038)

  • 1. In primary breast cancer the mitotic activity yields similar prognostic information as the histological grade: a study with long-term follow-up.
    Bult P; Manders P; Straatman HM; Tjan-Heijnen VC; Beex LV; Hendriks J; Leer JW; Verbeek AL; Holland R
    Breast Cancer Res Treat; 2010 Jul; 122(1):77-86. PubMed ID: 19760038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume corrected mitotic index (M/V index), mitotic activity index (MAI), and histological grading in breast cancer.
    Lipponen PK; Collan Y; Eskelinen MJ
    Int Surg; 1991; 76(4):245-9. PubMed ID: 1663917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients.
    Gilje B; Nordgård O; Tjensvoll K; Janssen EA; Søiland H; Smaaland R; Baak JP
    Breast Cancer Res Treat; 2011 Jul; 128(1):137-46. PubMed ID: 21476002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of proliferation in lymph-node-negative breast cancer patients is age dependent.
    Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA; Gudlaugsson E;
    Eur J Cancer; 2007 Feb; 43(3):527-35. PubMed ID: 17110097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate prognostic evaluation of the mitotic activity index and fibrotic focus in node-negative invasive breast cancers.
    Baak JP; Colpaert CG; van Diest PJ; Janssen E; van Diermen B; Albernaz E; Vermeulen PB; Van Marck EA
    Eur J Cancer; 2005 Sep; 41(14):2093-101. PubMed ID: 16153819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours.
    Fiets WE; Bellot FE; Struikmans H; Blankenstein MA; Nortier JW
    Eur J Surg Oncol; 2005 Mar; 31(2):128-33. PubMed ID: 15698727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of the mitotic activity index in patients with primary breast cancer who were not treated with adjuvant systemic therapy.
    Manders P; Bult P; Sweep CG; Tjan-Heijnen VC; Beex LV
    Breast Cancer Res Treat; 2003 Jan; 77(1):77-84. PubMed ID: 12602906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years.
    Baak JP; van Diest PJ; Voorhorst FJ; van der Wall E; Beex LV; Vermorken JB; Janssen EA
    J Clin Oncol; 2005 Sep; 23(25):5993-6001. PubMed ID: 16135467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
    Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.
    Hansen S; Sørensen FB; Vach W; Grabau DA; Bak M; Rose C
    Histopathology; 2004 May; 44(5):428-36. PubMed ID: 15139990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic counts provide additional prognostic information in grade II mammary carcinoma.
    Lynch J; Pattekar R; Barnes DM; Hanby AM; Camplejohn RS; Ryder K; Gillett CE
    J Pathol; 2002 Mar; 196(3):275-9. PubMed ID: 11857489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer.
    Lipponen P; Papinaho S; Eskelinen M; Klemi PJ; Aaltomaa S; Kosma VM; Marin S; Syrjänen K
    Anticancer Res; 1992; 12(5):1533-8. PubMed ID: 1444217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
    Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer.
    Abdel-Fatah TM; Powe DG; Ball G; Lopez-Garcia MA; Habashy HO; Green AR; Reis-Filho JS; Ellis IO
    J Pathol; 2010 Dec; 222(4):388-99. PubMed ID: 20922713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
    Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
    Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.